Analysts Split on Health In Tech as Losses Persist Into 2027
Health In Tech, Inc. (NASDAQ: HIT) is drawing fresh scrutiny from Wall Street after Maxim Group issued a fresh round of quarterly EPS estimates that stretch losses out through fiscal 2027. The